CIK 0000875320 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in MA · fiscal year ends 12/31
| FY2025 | FY2024 | |
|---|---|---|
| Revenue (USD) | 12.0 B | 8.9 B |
| Net income (USD) | 4.0 B | 3.3 B |
| Diluted EPS (USD/shares) | 15.32 | 12.82 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-22 | 4 | FORM 4 | 2026-10-20 |
| 2026-10-22 | 3 | FORM 3 | 2026-10-20 |
| 2026-10-20 | 8-K | 8-K items 5.02 | 2026-10-20 |
| 2026-10-19 | 4 | FORM 4 | 2026-10-15 |
| 2026-10-19 | 4 | FORM 4 | 2026-10-15 |
| 2026-09-10 | 4 | FORM 4 | 2026-09-08 |
| 2026-09-10 | 3 | FORM 3 | 2026-09-08 |
| 2026-09-01 | 4 | FORM 4 | 2026-08-28 |
| 2026-09-01 | 8-K | 8-K items 5.02 | 2026-08-27 |
| 2026-08-31 | 4 | FORM 4 | 2026-08-27 |
| 2026-08-27 | 144 | 144 | |
| 2026-08-04 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-03 | 8-K | 8-K items 2.02,9.01 | 2026-08-03 |
| 2026-07-23 | 4 | FORM 4 | 2026-07-21 |
| 2026-07-23 | 4 | FORM 4 | 2026-07-21 |
| 2026-07-17 | 4 | FORM 4 | 2026-07-15 |
| 2026-07-17 | 4 | FORM 4 | 2026-07-15 |
| 2026-07-07 | 4 | FORM 4 | 2026-07-02 |
| 2026-07-07 | 4 | FORM 4 | 2026-07-02 |
| 2026-07-07 | 8-K | 8-K items 1.01,7.01,8.01,9.01 | 2026-07-06 |
| 2026-07-06 | 4 | FORM 4 | 2026-07-01 |
| 2026-07-02 | 144 | 144 | |
| 2026-07-02 | 144 | 144 | |
| 2026-07-01 | 144 | 144 | |
| 2026-06-30 | 4 | FORM 4 | 2026-06-26 |
Forms on file (last 1,000): 4 644, 144 188, 8-K 54, 10-Q 19, 3 15, SC 13G/A 13, S-8 POS 7, DEFA14A 7. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=VRTX (0.002 USD), /gw/filings/filings?ticker=VRTX&form=8-K, /gw/filings/facts?ticker=VRTX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange